Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,841,018
-
Total 13F shares
-
616,674
-
Share change
-
+160,770
-
Total reported value
-
$1,633,000
-
Price per share
-
$2.65
-
Number of holders
-
10
-
Value change
-
+$397,179
-
Number of buys
-
5
-
Number of sells
-
8
Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q3 2020
As of 30 Sep 2020,
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
616,674 shares.
The largest 10 holders included
Worth Venture Partners, LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Equitable Holdings, Inc., Bank of New York Mellon Corp, DIMENSIONAL FUND ADVISORS LP, MML INVESTORS SERVICES, LLC, MORGAN STANLEY, and Tower Research Capital LLC (TRC).
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.